Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.250
+0.150 (7.14%)
At close: Oct 28, 2026, 4:00 PM EDT
2.230
-0.020 (-0.89%)
Pre-market: Oct 29, 2026, 4:17 AM EDT
Alector Revenue
Alector had revenue of $3.32M in the quarter ending June 30, 2026, a decrease of -57.84%. This brings the company's total for the last twelve months to $13.86M, down -82.91% year-over-year. In the year 2025, Alector had annual revenue of $21.05M, down -79.07%. That makes Alector the 35,789th largest company in the world by revenue and 4,706th in the United States.
Revenue (ttm)
$13.86M
Revenue Growth
-82.91%
P/S Ratio
24.06
Revenue / Employee
$134,592
Employees
103
Market Cap
333.58M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.05M | -79.51M | -79.07% |
| Dec 31, 2024 | 100.56M | 3.50M | 3.60% |
| Dec 31, 2023 | 97.06M | -36.56M | -27.36% |
| Dec 31, 2022 | 133.62M | -73.47M | -35.48% |
| Dec 31, 2021 | 207.09M | 185.99M | 881.54% |
| Dec 31, 2020 | 21.10M | -121.00K | -0.57% |
| Dec 31, 2019 | 21.22M | -6.46M | -23.33% |
| Dec 31, 2018 | 27.68M | 23.94M | 641.02% |
| Dec 31, 2017 | 3.74M | 3.32M | 797.84% |
| Dec 31, 2016 | 416.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 132.69M |
| vTv Therapeutics | 36.84M |
| Scribe Therapeutics | 33.30M |
| Arcturus Therapeutics Holdings | 29.37M |
| X4 Pharmaceuticals | 15.85M |
| Opus Genetics | 9.86M |
ALEC News
- 12 days ago - Alector prices 36.6M shares of common stock at $2.05 in underwritten offering - TheFly
- 12 days ago - Alector Announces Pricing of Underwritten Offering - GlobeNewsWire
- 14 days ago - Alector price target raised to $8 from $5 at H.C. Wainwright - TheFly
- 15 days ago - Alector Transcript: Investor update - Transcripts
- 15 days ago - Alector Press release: Investor update - Filings
- 15 days ago - Alector Slides: Investor update - Filings
- 21 days ago - Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline - GlobeNewsWire
- 22 days ago - Alector price target raised to $3 from $2 at Morgan Stanley - TheFly